Skip to main content
. 2016 Sep 20;7(42):68943–68953. doi: 10.18632/oncotarget.12126

Table 1. Patient characteristics (N=282).

Characteristics No. %
Sex
 Male 200 70.9
 Female 82 29.1
Age, years
 Median 57.3
 Range 19-83
MSKCC Score
 Low 66 23.4
 Intermediate 178 63.1
 High 38 13.4
Heng Score
 Low 55 19.5
 Intermediate 158 56.0
 High 69 24.4
Pathology
 clear cell 233 82.6
 papillary 28 9.9
 sarcomatoid 21 7.5
Metastatic Sites
 1 131 46.5
 2 106 37.6
 3 34 12.1
 ≥4 8 2.8
Prior nephrectomy 219 77.6
Prior metastasectomy 10 3.5
Prior immunotherapy 51 18.1
Best response
 CR/PR 53 18.8
 SD 191 67.7
 PD 38 13.5
eosinophil >5% before treatment 12 4.1
eosinophil >5% in 1 month of treatment 65 23.0
eosinophil >5% in 2 months of treatment 101 35.0